GENTA INCORPORATED /DE/
4, 1998-09-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: VITALINK PHARMACY SERVICES INC, SC 13G/A, 1998-09-10
Next: GENTA INCORPORATED /DE/, 4, 1998-09-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Aries, Domestic Fund, LP
   787 Seventh Avenue
   48th Floor
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   Genta Incorporated /DE/
   GNTA
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   AUGUST/1998
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
Common Stock, par value    |8/19/9| P  | |    6,200         | A |  $0.625   |                   |  D   |
$0.01 per share            |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |8/20/9| P  | |    6,200         | A |  $0.625   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |8/24/9| P  | |    4,000         | A |  $0.719   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |8/25/9| P  | |    3,900         | A |  $0.730   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |8/27/9| P  | |    4,200         | A |  $0.791   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |8/28/9| P  | |    4,100         | A |  $0.813   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |8/31/9| P  | |    4,450         | A |  $0.875   |   5,368,899       |  D   |
                           |8     |    | |                  |   |           |                   |      |                           |
___________________________________________________________________________________________________________________________________|

<PAGE>

<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------|
Series A Convertible P|$8.27   |08/24|P   | | 1,300     |A  |N/A  |N/A  |Common Stock|  9,432|$6.80  |29,300      |D  |            |
referred Stock, par va|        |/98  |    | |           |   |     |     |            |       |       |            |   |            |
lue $.001 per share   |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
See Attachment A

SIGNATURE OF REPORTING PERSON
/s/Lindsay A. Rosenwald, M.D.
- ---------------------------------------------------------
Lindsay A. Rosenwald, M.D., President
Paramount Capital Asset Management, Inc., General Partner
Aries Domestic Fund, L.P.
DATE
09/10/98

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed.
        If space provided is insufficient, see Instruction 6 for procedure.


Potential persons who are to respond to the collection of information  contained
in this form are not  required to respond  unless the form  displays a currently
valid OMB Number.


<PAGE>

                                 Attachment A


       Reporting Person:                  The Aries Domestic Fund, L.P.
       Issuer:                            Genta Incorporated (GNTA)
       Statement For:                     August 1998

         Paramount Capital Asset  Management,  Inc.  ("Paramount"),  the General
Partner of the Aries Domestic Fund, L.P. (the "Partnership"), also serves as the
Investment  Manager  to The Aries  Trust (the  "Trust"  and,  together  with the
Partnership,  the  "Aries  Funds"),  a Cayman  Islands  trust,  which  also owns
securities of the Issuer. Lindsay A. Rosenwald, M.D., is the sole shareholder of
Paramount.  Paramount and Dr.  Rosenwald  disclaim  beneficial  ownership of the
securities held by the Partnership and the Trust,  except to the extent of their
pecuniary interest therein. Pursuant to certain agreements, the Aries Funds have
the right to designate a majority of the Issuer's  Board of Directors,  however,
the Reporting Person disclaims status as a Director of the Issuer.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission